Effect of HepG2-Derived Exosome with PDGF-D Knockdown on Transformation of Normal Fibroblasts into Tumor-Associated Fibroblasts in Liver Cancer
Frontiers in Bioscience-Landmark · 2025
DOI: 10.31083/fbl26045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2025. Verfasst von Yan-Yan Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Tongde Hospital of Zhejiang Province, 310012 Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Exosomes, Liver Neoplasms, Cancer-Associated Fibroblasts, Platelet-Derived Growth Factor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
It is known that the transformation of liver cancer-mediated fibroblasts into cancer-related fibroblasts (CAFs) is beneficial to the development of liver cancer. However, the specific mechanism is still unclear.
Methods
Human hepatocarcinoma (HepG2) cells were treated with short hairpin RNA (shRNA) of platelet-derived growth factor-D (shPDGF-D) vector, and the exosomes secreted by the cells were separated using ultracentrifugation and identified by using nanoparticle tracking analysis, transmission electron microscope, and western blot analysis. Exosomes were co-cultured with mouse primary fibroblasts, and then the activity, proliferation, cell cycle, migration, epithelial-mesenchymal transition- (EMT-) and CAF marker-related protein expression levels of fibroblasts were determined by cell counting kit-8 (CCK-8), immunofluorescence, flow cytometry, wound healing, real-time reverse transcription-PCR, and western blotting assays, respectively. Co-cultured fibroblasts were mixed with HepG2 cells and injected subcutaneously into mice to construct animal models. The size and weight of xenograft tumor and the expression of epithelial-mesenchymal transition- (EMT-), angiogenesis- and CAFs marker-related proteins were detected.
Results
The exosomes inhibited the proliferation, migration, EMT, and induced cell cycle arrest, as well as decreased the expression of α-SMA, FAP, MMP-9, and VEGF in fibroblasts. In vivo, sh-PDGF-D inhibited tumor growth, reduced the expressions of CD31, vimentin, α-SMA, FAP, MMP9, and VEGF, and promoted the expression of E-cadherin.
Conclusions
Exosomes derived from HepG2 cells transfected with shPDGF-D prevent normal fibroblasts from transforming into CAFs, thus inhibiting angiogenesis and EMT of liver cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Tongde Hospital of Zhejiang Province, 310012 Hangzhou, Zhejiang, China.
Zitieren
APA
Wu, Y. Y., Yu, L. S., Zhou, H. Y., & Xue, J. C. (2025). Effect of HepG2-Derived Exosome with PDGF-D Knockdown on Transformation of Normal Fibroblasts into Tumor-Associated Fibroblasts in Liver Cancer. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl26045
Vancouver
Wu YY, Yu LS, Zhou HY, Xue JC. Effect of HepG2-Derived Exosome with PDGF-D Knockdown on Transformation of Normal Fibroblasts into Tumor-Associated Fibroblasts in Liver Cancer. Frontiers in Bioscience-Landmark. 2025. doi:10.31083/fbl26045
BibTeX
@article{Wu2025,
author = {Wu, Yan-Yan and Yu, Liu-Shen-Yan and Zhou, Han-Yu and Xue, Jun-Chao},
title = {Effect of HepG2-Derived Exosome with PDGF-D Knockdown on Transformation of Normal Fibroblasts into Tumor-Associated Fibroblasts in Liver Cancer},
journal = {Frontiers in Bioscience-Landmark},
year = {2025},
doi = {10.31083/fbl26045}
}
EUVIMED